TasimelteonTasimelteon, sold under the brand name Hetlioz, is a medication approved by the U.S. Food and Drug Administration (FDA) in January 2014, for the treatment of non-24-hour sleep–wake disorder (also called non-24, N24 and N24HSWD). Read from the Drugbox of the Wikipedia article Tasimelteon, revision 1329184391.

Property

Value

Formula

C15H19NO2, 245.32 g/mol

Protein binding

89.5 %

Elimination half-life

1.3 h

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.